SG Americas Securities
RKDA icon

SG Americas Securities’s Arcadia Biosciences RKDA Stock Holding History

SG Americas Securities’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-13
Closed -$32K – 2936
2015
Q3 		$32K Sell
13
-6
-32% -$25K ﹤0.01% 1995
2015
Q2 		$98K Buy
+19
New +$118K ﹤0.01% 2376

Other funds holding RKDA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

SG Americas Securities's RKDA Position: Q4 2015 in Review

SG Americas Securities sold out of Arcadia Biosciences (RKDA) in Q4 2015, closing a stake of 13 shares — an estimated $32K sold.

SG Americas Securities first reported a position in RKDA in Q2 2015 and held it in 2 quarters. The position peaked at $98K in Q2 2015. 26 funds tracked by Wall St. Rank hold RKDA as of Q4 2015.

  • SG Americas Securities reported no remaining Arcadia Biosciences position as of Q4 2015 after selling out during the quarter.
  • SG Americas Securities sold 13 Arcadia Biosciences shares in Q4 2015, an estimated $32K.
  • SG Americas Securities first reported a position in Arcadia Biosciences in Q2 2015 and held it in 2 quarters.
  • SG Americas Securities's Arcadia Biosciences position peaked at $98K in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2015.

Based on SG Americas Securities's 13F filing for Q4 2015, filed 12 Feb 2016.